Prof. Dr . Mahsa Hadipour Jahromy | Biomedical Awards | Excellence in Research

Prof. Dr . Mahsa Hadipour Jahromy , Islamic Azad University, Iran

Mahsa Hadipour Jahromy is an Associate Professor at Islamic Azad University, Tehran Medical Sciences, Iran. She holds a Pharm D in Pharmacy from Shahid Beheshti University of Medical Sciences and a PhD in Medical Pharmacology from Tehran University of Medical Sciences, with research conducted at Cardiff University, UK. Her research interests span various aspects of pharmacology, with a focus on biomedical applications, including the effects of herbal extracts on physiological systems, the pharmacological evaluation of novel compounds, and the development of potential treatments for conditions such as osteoarthritis and depression. Jahromy has authored numerous journal articles and conference papers, and she has been recognized with awards for her contributions to complementary medicine research. Additionally, she has translated pharmacology texts into Persian and authored educational materials on behavioral tests in laboratory mice.

Professional Profile:

Google Scholar

👩‍🎓 Education:

Mahsa Hadipour Jahromy pursued her academic journey in the field of pharmacology with dedication and excellence. She completed her Ph.D. in Medical Pharmacology at Tehran University of Medical Sciences, Tehran, Iran, spanning from 1998 to 2003. Her doctoral research delved into the intricate realm of anesthesia, focusing on the effects of binary combinations of intravenous anesthetics on alpha-1 glycine receptors heterologously expressed in Xenopus laevis oocytes. This work represented a significant contribution to understanding the pharmacological interactions within the human body.

🏅 Honors & Awards:

Mahsa Hadipour Jahromy’s contributions to the field of complementary medicine research were recognized with the Best Poster Award at the 2nd Annual International Congress on Complementary Medicine Research held in Munich, Germany, in 2007. Her poster presentation stood out for its innovative approach and valuable insights, highlighting her dedication to advancing knowledge in this interdisciplinary field . In addition to her research accolades, Mahsa was honored as an Outstanding Lecturer of the university in both 2010 and 2012. This recognition reflects her exceptional teaching abilities and commitment to academic excellence. Through her engaging lectures and mentorship, Mahsa has inspired countless students and colleagues, leaving a lasting impact on the educational landscape of her institution.

Publication Top Notes:

Chondroprotective effects of pomegranate juice on monoiodoacetate‐induced osteoarthritis of the knee joint of mice
M Hadipour‐Jahromy, R Mozaffari‐Kermani
Phytotherapy Research: An International Journal Devoted to Pharmacological …, 89 citations, 2010.
The effect of chronic administration of methylphenidate on morphometric parameters of testes and fertility in male mice
S Fazelipour, MH Jahromy, Z Tootian, SB Kiaei, MT Sheibani, N Talaee
Journal of Reproduction & Infertility, 46 citations, 2012.
Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
N Aboulghasemi, MH Jahromy, A Ghasemi
IBRO reports, 19 citations, 2019.
Binary combinations of propofol and barbiturates on human α1 glycine receptors expressed in Xenopus oocytes
M Hadipour-Jahromy, S Daniels
European journal of pharmacology, 19 citations, 2003.
Effects of blackberry (Morus nigra) fruit juice on levodopa-induced dyskinesia in a mice model of Parkinson’s disease
Z Fahimi, MH Jahromy
Journal of Experimental Pharmacology, 17 citations, 2018.

Assoc. Prof. Dr. Hui Xiong, China Pharmaceutical University, china

Hui Xiong is an accomplished researcher and associate professor at China Pharmaceutical University, specializing in the development of multifunctional nanosystems for cancer therapy. With a Ph.D. in Biotechnology, her work focuses on innovative drug delivery platforms and combination therapies targeting various aspects of tumor biology. Through her extensive research experience and numerous publications, she has made significant contributions to advancing cancer treatment strategies. Additionally, Hui Xiong has secured funding from prestigious foundations to support her groundbreaking research endeavors.

Professional Profile:

Scopus

🎓 Education and Work Background

Dr. Hui Xiong holds a Ph.D. in Biotechnology from Banasthali Vidhyapith Rajasthan, completed in 2018 with a remarkable score of 81.36%. Prior to that, she earned her M.Sc. in Biotechnology from the same institution in 2013, achieving a commendable score of 76.35%. Her academic journey began with a Bachelor’s degree in Biotechnology from Sam Higginbottom University of Agriculture, Technology and Science Prayagraj, where she graduated with an outstanding CGPA of 9.96 in 2011.

💼 Work Experience

Dr. Hui Xiong has served as an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University (CPU) since 2017, contributing significantly to the field of pharmaceutical sciences. Prior to her current role, she worked as a Postdoctoral Researcher at CPU from 2017 to 2020, where she made notable contributions to research in pharmaceutics. Dr. Xiong embarked on her academic journey as a Ph.D. student in the same department at CPU from 2012 to 2017, showcasing her dedication to advancing pharmaceutical research. Her educational foundation was laid during her undergraduate years at the College of Pharmacy, Hubei University of Chinese Medicine, where she honed her skills and passion for the field from 2008 to 2012.

🏆 Foundations

Dr. Hui Xiong’s research endeavors have garnered recognition and support from prestigious organizations such as the National Natural Science Foundation of China. Her innovative projects have received funding from this esteemed foundation, underscoring the significance and impact of her contributions to the field of pharmaceutical sciences. This funding serves as a testament to Dr. Xiong’s expertise and the importance of her research in advancing scientific knowledge and addressing critical challenges in the pharmaceutical industry.